Nicole S Carlson1, Elizabeth J Corwin1, Nancy K Lowe2. 1. 1 Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA. 2. 2 College of Nursing, University of Colorado, Aurora, CO, USA.
Abstract
BACKGROUND: Synthetic oxytocin, the primary tool for labor augmentation, is less effective among obese women, leading to more unplanned cesarean deliveries for slow labor progress. It is not known if obese women require higher doses of oxytocin due to maternal, fetal, or labor factors related to maternal obesity. OBJECTIVES: This study had two main objectives: (1) examine the influence of maternal body mass index (BMI) on hourly doses of oxytocin from augmentation initiation until vaginal delivery in obese women; and (2) examine the influence of other maternal, fetal, and labor factors on hourly doses of oxytocin in obese women. STUDY DESIGN: Longitudinal study of a cohort ( N = 136) of healthy, nulliparous, spontaneously laboring obese women (BMI ≥ 30 kg/m2) who received oxytocin augmentation and achieved vaginal delivery. We performed iterative multilevel analyses to examine the influence of maternal BMI and other factors on hourly oxytocin doses. RESULTS: Maternal BMI explained 16.56% (95% confidence interval [CI] = [13.7, 20.04], p < .001) of the variance in hourly oxytocin doses received in a multilevel model controlling for influence of maternal, fetal, and labor characteristics. Maternal age, gestational age, status of amniotic membranes at hospital admission, and admission cervical dilation examination were not significant; however, neonatal birthweight and cervical dilation at oxytocin initiation were significant predictors of hourly oxytocin dose in these women ( p < .001). CONCLUSIONS: Even when parturition preparation has progressed adequately for spontaneous labor initiation, there still may be some obesity-related blunting of myometrial contractility and response to oxytocin used for augmentation.
BACKGROUND: Synthetic oxytocin, the primary tool for labor augmentation, is less effective among obesewomen, leading to more unplanned cesarean deliveries for slow labor progress. It is not known if obesewomen require higher doses of oxytocin due to maternal, fetal, or labor factors related to maternal obesity. OBJECTIVES: This study had two main objectives: (1) examine the influence of maternal body mass index (BMI) on hourly doses of oxytocin from augmentation initiation until vaginal delivery in obesewomen; and (2) examine the influence of other maternal, fetal, and labor factors on hourly doses of oxytocin in obesewomen. STUDY DESIGN: Longitudinal study of a cohort ( N = 136) of healthy, nulliparous, spontaneously laboring obesewomen (BMI ≥ 30 kg/m2) who received oxytocin augmentation and achieved vaginal delivery. We performed iterative multilevel analyses to examine the influence of maternal BMI and other factors on hourly oxytocin doses. RESULTS: Maternal BMI explained 16.56% (95% confidence interval [CI] = [13.7, 20.04], p < .001) of the variance in hourly oxytocin doses received in a multilevel model controlling for influence of maternal, fetal, and labor characteristics. Maternal age, gestational age, status of amniotic membranes at hospital admission, and admission cervical dilation examination were not significant; however, neonatal birthweight and cervical dilation at oxytocin initiation were significant predictors of hourly oxytocin dose in these women ( p < .001). CONCLUSIONS: Even when parturition preparation has progressed adequately for spontaneous labor initiation, there still may be some obesity-related blunting of myometrial contractility and response to oxytocin used for augmentation.
Authors: Jun Zhang; Helain J Landy; D Ware Branch; Ronald Burkman; Shoshana Haberman; Kimberly D Gregory; Christos G Hatjis; Mildred M Ramirez; Jennifer L Bailit; Victor H Gonzalez-Quintero; Judith U Hibbard; Matthew K Hoffman; Michelle Kominiarek; Lee A Learman; Paul Van Veldhuisen; James Troendle; Uma M Reddy Journal: Obstet Gynecol Date: 2010-12 Impact factor: 7.661
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Audrey T Moynihan; Mark P Hehir; Siobhan V Glavey; Terry J Smith; John J Morrison Journal: Am J Obstet Gynecol Date: 2006-05-02 Impact factor: 8.661
Authors: Jeanette R Chin; Erick Henry; Calla M Holmgren; Michael W Varner; D Ware Branch Journal: Am J Obstet Gynecol Date: 2012-06-23 Impact factor: 8.661
Authors: Louise Lundborg; Xingrong Liu; Katarina Åberg; Anna Sandström; Ellen L Tilden; Olof Stephansson; Mia Ahlberg Journal: Sci Rep Date: 2021-07-05 Impact factor: 4.379
Authors: Lin Zhang; James Troendle; D Ware Branch; Matthew Hoffman; Jun Yu; Lixia Zhou; Tao Duan; Jun Zhang Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240